The problem, said Nishibayashi, is that because vaccines are generally administered around the time that autism is first diagnosed in children -- the first two years of life -- there is no way to prove to an absolute statisticalcertainty that the two aren't related.
But the Tevatron results are currently at the one-sigma level of certainty - a lower level of statistical significance than those presented by the Atlas and CMS teams.